Loading...

Financial Summary


Insys Therapeutics Inc.

Insys Therapeutics Inc. (INSY)

Healthcare
Buy
A
Market Info
Financial Info
Financial Modelling
Symbol INSY
Price 0.3$
Beta 2.48
Volume Avrg. 0.63M
Market Cap 0.02B
Shares (2018) 74,073.66K
Last Div 0
Dividend Yield -
DCF Unlevered -1.00 Strong Sell
DCF Levered 1.30 Strong Buy
ROE 288.88% Strong Buy
ROA -173.89% Strong Sell
Operating Margin -155.61% Strong Sell
Debt / Equity 0.00% Neutral
P/E - Neutral
P/B - Neutral

Income Statement

Download INSY income statement Download INSY income statement
Year 20112012201320142015201620172018
Revenue -15.4899.29219.09330.32242.28140.6982.08
Cost of Revenue -7.6312.6622.5828.8525.3920.6410.80
Gross Profit -7.8586.62196.51301.47216.88120.0571.28
R&D Expenses 8.336.308.5033.1456.7873.9162.9557.57
Sales, General and Administrative Expense 9.0419.5845.57102.39143.62131.74116.44124.65
Operating Expenses 17.3731.2954.06135.52211.01209.56339.08199.00
Operating Income -17.37-23.4432.5660.9990.467.33-219.03-127.72
Interest Expense 1.962.680.95-----
Earnings before Tax -19.36-24.3831.5861.1490.998.42-217.19-126.41
Income Tax Expense ---8.8025.0932.940.839.64-1.90
Net Income -19.36-24.3840.3836.0558.057.59-226.84-124.51
Net Income - Non-Controlling int --------
Net Income - Discounted ops --------
Net Income Com -1.63-24.3840.3836.0558.057.59-226.84-124.51
Preferred Dividends -17.73-------
Earnings Per Share Basic -0.69-0.870.780.520.810.11-3.12-1.68
Earnings Per Share Diluted -0.69-0.870.700.490.770.10-3.12-1.68
Weighted Average Shares Outstanding 2.3527.9551.8468.7671.5971.6472.6474.07
Weighted Average Shares Outstanding (Diluted) 2.3527.9557.4773.3475.7174.1772.6474.07
Dividend per Share --------
Gross Margin -0.510.870.900.910.900.850.87
EBITDA Margin --1.290.350.290.290.06-1.49-1.45
EBIT Margin --1.400.330.280.280.03-1.54-1.54
Profit Margin --1.570.410.170.180.03-1.61-1.52
Free Cash Flow margin --0.000.000.000.000.00-0.00-0.00
EBITDA -16.01-20.0334.3163.6496.2814.67-209.86-118.83
EBIT -17.40-21.6932.5361.1490.998.42-217.19-126.41
Consolidated Income -19.36-24.3840.3836.0558.057.59-226.84-124.51
Earnings Before Tax Margin --1.580.320.280.280.03-1.54-1.54
Net Profit Margin --1.580.410.160.180.03-1.61-1.52

Balance Sheet Statement

Download INSY income statement Download INSY income statement
Year 20112012201320142015201620172018
Cash and cash equivalents 0.010.3645.7858.1179.52104.6432.0031.55
Short-term investments ---24.7679.5878.2485.1964.13
Cash and short-term investments 0.010.3645.7882.86159.09182.88117.1995.68
Receivables -3.0916.3126.5447.2720.6521.5112.61
Inventories 6.747.0914.5334.7841.7220.4117.418.61
Property, Plant & Equipment Net 7.486.7910.1329.8738.3843.1755.1752.09
Goodwill and Intangible Assets 5.40-------
Long-term investments ---23.2643.2253.8046.738.45
Tax assets --12.0412.2117.6123.24--
Total non-current assets 2.47--3.788.547.935.69128.85
Total current assets 13.056.8518.4168.6999.23126.49103.1466.23
Total assets 20.9618.74100.56215.12351.29356.14279.08192.53
Payables 7.906.4812.1727.4535.6127.3630.4450.78
Short-term debt 52.8170.24------
Total current liabilities 61.7083.4221.0845.6890.4478.61207.18106.78
Long-term debt --------
Total debt 52.8170.24------
Deferred revenue -3.77----1.11-
Tax Liabilities ---3.788.547.935.693.77
Deposit Liabilities --------
Total non-current liabilities 2.47--3.788.547.935.69128.85
Total liabilities 64.1783.4221.0849.4598.9886.55212.87235.63
Other comprehensive income ----0.02-0.15-0.30-0.44-0.27
Retained earnings (deficit) -105.03-129.41-89.03-51.065.0712.66-212.42-336.08
Total stockholders equity --------
Investments ---48.02122.80132.03131.9272.57
Net Debt 52.8069.88-45.78-82.86-159.09-182.88-117.19-95.68
Other Assets 1.161.345.532.243.975.7019.839.40
Other Liabilities 0.986.708.9118.2254.8351.26176.7456.00

Cash Flow Statement

Download INSY income statement Download INSY income statement
Year 20112012201320142015201620172018
Depreciation & Amortization 1.391.661.792.505.296.257.347.58
Stock-based compensation 1.692.763.59-6.168.2923.3216.0212.02
Operating Cash Flow -15.38-13.6324.2550.59102.2858.90-60.66-55.99
Capital Expenditure -0.60-1.02-5.13-22.25-13.84-10.61-16.66-6.09
Acquisitions and disposals --------
Investment purchases and sales ----48.41-76.33-11.42-1.1559.49
Investing Cash Flow --------
Insurance (repayment) of debt --------
Insurance (buybacks) of shares --------
Dividend payments --------
Financing Cash Flow 15.9315.0026.3032.399.31-11.745.832.14
Effect of forex changes on cash --------
Net cash flow / Change in cash -0.050.3545.0212.7221.4125.13-72.64-0.45
Free Cash Flow -15.98-14.6519.1228.3488.4448.29-77.32-62.08
Net Cash/Marketcap -0.00-0.000.000.000.000.000.000.00

Retained Earning Schedule

Year 20112012201320142015201620172018
Retained Earnings (Previous Year) --105-129-89-51513-212
Net Income -19-244036588-227-125
Stock Dividends -86--2-2-21
Divident Paid --------
Retained Earnings -105-129-89-51513-212-336
Year 20112012201320142015201620172018
Gross PPE -771030384355
Annual Depreciation 808422215293
Capital Expenditure -1-1-5-22-14-11-17-6
Net PPE 77103038435552

Intangible and Goodwill Schedule

Year 20112012201320142015201620172018
Intangible and Goodwill (Previous Year) -5------
New Purchases ----48-76-11-159
Intangible and Goodwill 5-------
Insys Therapeutics Inc.

Insys Therapeutics Inc. (INSY)

0.3
0 (0.00%)

About


Healthcare
Biotechnology
NASDAQ Global Market

Insys Therapeutics Inc develops and commercializes drugs delivery systems targeting the oncology space. The company manufactures cannabinoid formulation, and sublingual spray drug delivery technology for the US and Europe markets.